Literature DB >> 8054503

Naturally occurring tumors in dogs as comparative models for cancer therapy research.

K A Hahn1, L Bravo, W H Adams, D L Frazier.   

Abstract

The United States pet population has been a vastly underutilized resource for cancer therapy studies. Naturally occurring tumors in dogs develop twice as frequently as in man, have histopathologic features and a biologic behavior similar to tumors in man, and progress at a more rapid rate than in man. Cancer is one of the leading causes of death in man and dogs. The canine malignancies that are of practical use for comparative therapeutic studies include lymphoma, mammary tumors, oral melanoma, lung tumors, nasal tumors, soft tissue sarcomas, and osteosarcoma. This report will discuss the comparative nature of these malignancies and the current trends in clinical cancer research, namely dose intensification and biomodulation, using naturally occurring tumors in client-owned dogs.

Entities:  

Mesh:

Year:  1994        PMID: 8054503

Source DB:  PubMed          Journal:  In Vivo        ISSN: 0258-851X            Impact factor:   2.155


  16 in total

1.  Development and characterization of 5 canine B-cell lymphoma cell lines.

Authors:  Allison L Zwingenberger; William Vernau; Changying Shi; Wensheng Yan; Xinbin Chen; Ira K Gordon; Michael S Kent
Journal:  Leuk Res       Date:  2011-12-01       Impact factor: 3.156

2.  Amputation and dexniguldipine as treatment for canine appendicular osteosarcoma.

Authors:  K A Hahn; A M Legendre; H M Schuller
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

3.  Pharmacokinetics and derivation of an anticancer dosing regimen for PAC-1, a preferential small molecule activator of procaspase-3, in healthy dogs.

Authors:  Pamela W Lucas; Joanna M Schmit; Quinn P Peterson; Diana C West; Danny C Hsu; Chris J Novotny; Levent Dirikolu; Mona I Churchwell; Daniel R Doerge; Laura D Garrett; Paul J Hergenrother; Timothy M Fan
Journal:  Invest New Drugs       Date:  2010-05-25       Impact factor: 3.850

Review 4.  Dog models of naturally occurring cancer.

Authors:  Jennie L Rowell; Donna O McCarthy; Carlos E Alvarez
Journal:  Trends Mol Med       Date:  2011-03-24       Impact factor: 11.951

5.  Affinity of the alpha4-beta1 integrin-targeting peptide LLP2A to canine lymphoma.

Authors:  Allison L Zwingenberger; Michael S Kent; Changying Shi; Sandra L Taylor; Xiucui Chen; Kit S Lam
Journal:  Vet Immunol Immunopathol       Date:  2011-11-25       Impact factor: 2.046

Review 6.  Comparative oncology today.

Authors:  Melissa C Paoloni; Chand Khanna
Journal:  Vet Clin North Am Small Anim Pract       Date:  2007-11       Impact factor: 2.093

7.  Blood vessel density in canine osteosarcoma.

Authors:  B L Coomber; J Denton; A Sylvestre; S Kruth
Journal:  Can J Vet Res       Date:  1998-07       Impact factor: 1.310

8.  Five decades of progress in haematopoietic cell transplantation based on the preclinical canine model.

Authors:  M Lupu; R Storb
Journal:  Vet Comp Oncol       Date:  2007-03       Impact factor: 2.613

9.  Anti-tumor effects of nitrosylcobalamin against spontaneous tumors in dogs.

Authors:  Joseph A Bauer; Gerald Frye; Anne Bahr; Jennifer Gieg; Peter Brofman
Journal:  Invest New Drugs       Date:  2009-06-27       Impact factor: 3.850

10.  Frequent genetic defects in the p16/INK4A tumor suppressor in canine cell models of breast cancer and melanoma.

Authors:  Farruk M Lutful Kabir; Patricia DeInnocentes; Allison Church Bird; R Curtis Bird
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-05-20       Impact factor: 2.416

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.